Becton, Dickinson And Co. BDX

NYS: BDX | ISIN: US0758871091   23/03/2026
156,23 USD (+1,36%)
(+1,36%)   23/03/2026

5 maart 2026 · BD fait progresser le traitement de l'artère iliaque dans l'Union européenne · Persbericht

2 maart 2026 · BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation · Persbericht

25 februari 2026 · Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase · Persbericht

25 februari 2026 · Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap · Persbericht

23 februari 2026 · BD to Present at Barclays 28th Annual Global Healthcare Conference · Persbericht

23 februari 2026 · BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency · Persbericht

19 februari 2026 · Lanesha Minnix Named General Counsel for BD · Persbericht

10 februari 2026 · Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities · Persbericht

9 februari 2026 · BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation · Persbericht

9 februari 2026 · Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses · Persbericht

9 februari 2026 · BD Reports First Quarter Fiscal 2026 Financial Results · Persbericht

29 januari 2026 · BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care · Persbericht

27 januari 2026 · BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 · Persbericht

27 januari 2026 · BD to Announce Financial Results for its First Quarter of Fiscal 2026 · Persbericht

27 januari 2026 · BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business · Persbericht

27 januari 2026 · Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business · Persbericht

23 januari 2026 · BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation · Persbericht

21 januari 2026 · BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market · Persbericht

15 januari 2026 · BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System · Persbericht

14 januari 2026 · BD Names Shawn Bevec as Senior Vice President of Investor Relations · Persbericht

Mijn selecties